NCT06834074
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06834074
Title Expanded Access Program of Neladalkib (NVL-655) for Patients With Advanced ALK+ NSCLC (NVL-655-EAP)
Acronym NVL-655-EAP
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements Yes
Sponsors Nuvalent Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | GBR | FRA | ESP | CHE | CAN | AUS

Facility Status City State Zip Country Details
University of Colorado Anschutz School of Medicine AVAILABLE Aurora Colorado 80045 United States Details
Massachusetts General Hospital AVAILABLE Boston Massachusetts 02114 United States Details
Dana-Farber Cancer Institute AVAILABLE Boston Massachusetts 02215 United States Details
Henry Ford Cancer Institute AVAILABLE Detroit Michigan 48202 United States Details
Washington University in St. Louis AVAILABLE St Louis Missouri 63110 United States Details
NYU Langone Health AVAILABLE New York New York 10016 United States Details
Memorial Sloan Kettering Cancer Center AVAILABLE New York New York 10065 United States Details
Duke University AVAILABLE Durham North Carolina 27708 United States Details
The Ohio State University AVAILABLE Columbus Ohio 43210 United States Details
Royal North Shore Hospital AVAILABLE St Leonards New South Wales 2065 Australia Details
Peter MacCallum Cancer Centre AVAILABLE Melbourne Victoria 3000 Australia Details
Cross Cancer Institute AVAILABLE Edmonton Alberta AB T6G 1Z2 Canada Details
BC Cancer - Vancouver AVAILABLE Vancouver British Columbia V5Z 4E6 Canada Details
Princess Margaret Hospital AVAILABLE Toronto Ontario ON M5G 2M9 Canada Details
Centre Leon Berard AVAILABLE Lyon Auvergne-Rhône-Alpes 69008 France Details
GCS IUCT Oncopole AVAILABLE Toulouse Occitanie 31059 France Details
CHU de Nantes AVAILABLE Nantes Pays de la Loire Region 44800 France Details
Institut Gustave Roussy AVAILABLE Villejuif Île-de-France Region 94800 France Details
Stichting Het Nederlands Kanker Instituut AVAILABLE Amsterdam North Holland 1066 CX Netherlands Details
Antoni van Leeuwenhoek Hospital AVAILABLE Amsterdam 1006 BE Netherlands Details
National University Hospital Singapore AVAILABLE Singapore 119074 Singapore Details
National Cancer Centre Singapore AVAILABLE Singapore 168583 Singapore Details
Seoul National University Hospital AVAILABLE Seoul Jongno-gu 03080 South Korea Details
Uomi Cancer Center-Clinica Tres Torres AVAILABLE Barcelona 08017 Spain Details
Hospital Universitario 12 de Octubre AVAILABLE Madrid 28041 Spain Details
Kantonsspital Luzern AVAILABLE Lucerne 6000 Switzerland Details
Ospedale Italiano di Lugano AVAILABLE Viganello 6962 Switzerland Details
National Taiwan University Hospital AVAILABLE Taipei 100 Taiwan Details
The Royal Marsden Hospital AVAILABLE Sutton Surrey SM2 5PT United Kingdom Details
The Royal Marsden Hospital AVAILABLE London UK SW3 6JJ United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field